论文部分内容阅读
目的:探究双歧杆菌三联菌(益生菌)对感染性腹泻新生儿生理的调节作用。方法:选取2013年2月至2015年2月我院收治的130例感染性腹泻新生儿患者为研究对象,将其分为对照组和治疗组,每组65例患者,对照组采用常规性治疗方式,治疗组患者在对照组的基础上采用益生菌进行治疗,对新生儿的生理调节作用进行比较分析。结果:在本次研究中,对照组的治疗总有效率为69.2%,治疗组的治疗总有效率为89.2%,治疗组的治疗效果明显优于对照组,比较结果差异性显著,具有统计学意义(P<0.05)。对照组出现不良反应的患者有10例,不良反应率为15.4%,治疗组出现不良反应的患者有3例,不良反应率为4.6%,两组各项数据比较结果有明显的差异,具有统计学意义(P<0.05)。治疗组的腹泻、呕吐和发热等不良症状消失时间明显小于对照组,比较结果差异性显著,具有统计学意义(P<0.05)。结论:对感染性腹泻新生儿采用益生菌进行辅助治疗,其临床调节作用明显,能有效减少临床不良反应,因此值得临床广泛推广应用。
Objective: To investigate the regulation of bifidobacterium triple bacteria (probiotics) on neonatal physiology of infectious diarrhea. Methods: A total of 130 neonates with infectious diarrhea who were admitted to our hospital from February 2013 to February 2015 were selected as the control group and control group, with 65 patients in each group. The control group was treated by conventional therapy Way, treatment group patients in the control group based on the use of probiotics for the treatment of neonatal physiological regulation of comparative analysis. Results: In this study, the total effective rate of the control group was 69.2%, the total effective rate of the treatment group was 89.2%, the treatment group was significantly better than the control group, the results were significantly different, with statistical Significance (P <0.05). There were 10 patients with adverse reactions in the control group, the adverse reaction rate was 15.4%, 3 patients with adverse reactions in the treatment group, the adverse reaction rate was 4.6%, there was significant difference between the two groups of data, with statistics Significance (P <0.05). Treatment group of diarrhea, vomiting and fever and other adverse symptoms disappeared significantly less than the control group, the difference was significant, with statistical significance (P <0.05). Conclusion: Adjuvant therapy with probiotics in newborn infants with infectious diarrhea can significantly reduce the clinical adverse reactions, which is worth widely clinical application.